
The Intercept @theintercept
Eli Lilly is one of the three companies that control the insulin industry. Last year, Eli Lilly collected over $2.4 billion in revenue from its insulin products, including the brand Humalog, with roughly $1.3 billion of that from U.S.-based sales. https://t.co/EFCmoMNJo4 — PolitiTweet.org